Optic neuritis is an inflammatory demyelinating disease of the optic nerve and is one of the most common causes of acute monocular vision loss in young adults (particularly women). It has a strong association with multiple sclerosis (MS): optic neuritis may be the first presentation of MS (50% conversion to MS) and 70% of MS patients develop optic neuritis during the disease course. Typical optic neuritis is retrobulbar in location (without disc edema), characterized by retrobulbar pain (especially increasing with eye movements), RAPD (relative afferent pupillary defect), and decreased color saturation. Radiologically, T2/STIR hyperintensity and contrast enhancement of the optic nerve on MRI are diagnostic findings. In neuromyelitis optica spectrum disorder (NMOSD / Devic's disease) and MOG-IgG associated disease, optic neuritis tends to be more severe, bilateral, with long-segment involvement and extension to the chiasm — this distinction changes the treatment approach. High-dose intravenous methylprednisolone is the standard treatment; visual prognosis is generally good in typical MS-associated optic neuritis.
Age Range
18-50
Peak Age
32
Gender
Female predominant
Prevalence
Uncommon
Optic neuritis develops when a T-cell mediated autoimmune inflammatory process targets the optic nerve myelin — activated T-lymphocytes cross the blood-brain barrier and the optic nerve undergoes demyelination similar to periventricular white matter. Demyelination disrupts saltatory conduction along the axon, reducing nerve conduction velocity and causing signal loss — this is the neurophysiological basis of vision loss and color desaturation. T2/STIR hyperintensity on MRI reflects increased free water due to inflammatory edema and demyelination; enhancement indicates gadolinium leakage resulting from blood-nerve barrier breakdown — an indicator of active inflammation. In NMOSD, anti-AQP4 antibodies target astrocytic endfeet causing complement-mediated tissue damage; this mechanism results in more severe, necrotizing inflammation and long-segment involvement — radiologically reflected as longer-segment T2 hyperintensity, optic nerve thickening, and extension to the chiasm. In MOG-IgG disease, perineuritis (optic nerve sheath inflammation) is predominant and 'streaky' perineural enhancement is characteristic.
T2/STIR hyperintensity of the optic nerve (demyelination and inflammatory edema) combined with enhancement on contrast-enhanced fat-suppressed T1 (blood-nerve barrier breakdown) on MRI is the pathognomonic radiological combination of optic neuritis. STIR sequence is the most sensitive for detection of optic nerve lesions. Short-segment involvement (<50%) suggests typical MS-associated optic neuritis, while long-segment involvement (>50%), bilateral involvement, and extension to the chiasm should suggest NMOSD/MOG-IgG disease.
On T2-weighted (particularly fat-suppressed T2 / STIR) MRI, focal or segmental hyperintensity is seen in the affected optic nerve. Hyperintensity is generally located in the retrobulbar segment (intraorbital) — it may also involve the intracanalicular or intracranial segment. In typical MS-associated optic neuritis, involvement is short-segment (<50% of optic nerve length, usually <1 cm). In NMOSD, involvement is long-segment (>50%, often entire nerve), may extend to the optic chiasm, and may be bilateral. In MOG-IgG disease, involvement may be long-segment and optic nerve sheath edema (perineuritis) is prominent. Optic nerve thickness may be normal or mildly increased. In the acute phase, T2 hyperintense edema may be seen in surrounding orbital fat. STIR sequence suppresses orbital fat signal through fat suppression, making optic nerve lesions more conspicuous — it is the most sensitive sequence for optic neuritis diagnosis.
Report Sentence
On STIR sequences, T2 hyperintensity measuring approximately ___ mm in length is observed in the retrobulbar segment of the ___ optic nerve, consistent with optic neuritis.
On contrast-enhanced fat-suppressed T1 MRI, enhancement is seen in the affected optic nerve segment — this is a direct indicator of active inflammation and blood-nerve barrier breakdown. Enhancement is generally in the same location and similar length as T2 hyperintensity. In MS-associated optic neuritis, enhancement is short-segment and focal. In NMOSD, enhancement is long-segment, prominent, and may extend to the chiasm. In MOG-IgG disease, perineural (sheath) enhancement is prominent — 'tram-track' or 'ring' pattern of enhancement around the optic nerve is pathognomonic. Enhancement decreases and disappears with treatment; persistence of enhancement indicates active disease. Contrast-enhanced fat-suppressed coronal and axial T1 sequences are mandatory for evaluation of optic nerve enhancement.
Report Sentence
On contrast-enhanced fat-suppressed T1-weighted sequences, enhancement is observed in the ___ segment of the ___ optic nerve, consistent with active optic neuritis.
On diffusion-weighted imaging, diffusion changes may be observed in the affected optic nerve segment in acute optic neuritis. Mild diffusion restriction (ADC decrease) has been reported in the acute inflammatory phase — this reflects diffusion restriction from cellular edema and inflammatory cell infiltration. DTI (Diffusion Tensor Imaging) as an advanced technique evaluates axons: decreased fractional anisotropy (FA) indicates demyelination, increased mean diffusivity (MD) indicates axonal damage. In the chronic phase, ADC increase is seen as a result of axonal loss and Wallerian degeneration. EPI-based DWI in the orbital region is susceptible to artifacts; readout-segmented DWI or RESOLVE technique improves orbital DWI quality. DWI is not the primary method for optic neuritis diagnosis but may provide additional information for severity assessment and prognosis prediction.
Report Sentence
On diffusion-weighted imaging, mild diffusion changes are observed in the affected optic nerve segment, consistent with acute inflammatory process.
On FLAIR (Fluid Attenuated Inversion Recovery) sequence, demyelinating plaques in brain parenchyma are assessed — brain MRI is mandatory for MS diagnosis and risk assessment in optic neuritis cases. MS-associated white matter lesions may be periventricular (Dawson fingers — ovoid lesions perpendicular to ventricular axis), juxtacortical (involving U-fibers), infratentorial (pons, cerebellum, peduncle), and spinal cord locations. Hyperintense plaques on FLAIR reflect increased free water (edema, demyelination, gliosis). Dissemination in space and time is assessed using Barkhof/McDonald criteria. With ≥2 white matter lesions, MS conversion risk is 72%, while without lesions the risk drops to 25% (ONTT study). The optic nerve itself cannot be evaluated on FLAIR because when CSF signal is suppressed the perineural area produces low signal and optic nerve lesions may be obscured — therefore STIR is preferred for optic nerve assessment.
Report Sentence
On FLAIR sequences, ___ periventricular/juxtacortical/infratentorial hyperintense lesions are observed in the brain parenchyma consistent with demyelinating disease (MS); should be evaluated regarding McDonald criteria.
On B-mode ultrasonography, increase in optic nerve sheath diameter (ONSD) may be seen in acute optic neuritis (normal <5 mm, increased >5.5 mm). A focal hypoechoic area (edema/inflammation) may be discerned in the optic nerve parenchyma. US is not the primary modality for optic neuritis diagnosis and has lower sensitivity than MRI, but can be used as a rapid screening tool when MRI is contraindicated or unavailable. Optic disc edema (papillitis — anterior optic neuritis) may be seen on US as optic disc protrusion. Increased perfusion on color Doppler may reflect vascular dilation. US is a practical tool for serial follow-up of treatment response (ONSD change).
Report Sentence
On ultrasonography, the ___ optic nerve sheath diameter is increased (___ mm); consistent with optic neuritis, MRI correlation is recommended.
Criteria
Young female (20-40 years), unilateral, retrobulbar pain, short-segment involvement; demyelinating lesions may accompany on brain MRI
Distinct Features
Short-segment (<1 cm) retrobulbar T2 hyperintensity and focal enhancement on MRI; optic nerve thickness normal or minimally increased; perineural enhancement minimal; visual prognosis good (vision recovers within 6 months in 90% of cases); rapid response to IV methylprednisolone; 50% conversion to MS within 15 years
Criteria
Anti-AQP4 antibody positive; long-segment involvement; may be bilateral; extension to chiasm; severe vision loss; steroid dependence
Distinct Features
Long-segment (>50%) T2 hyperintensity on MRI, prominent optic nerve thickening, extension to chiasm, bilateral involvement; more intense enhancement; visual prognosis poor — incomplete recovery common; recurrent attacks lead to permanent damage; MS medications (interferon beta) may exacerbate disease; plasmapheresis/rituximab/eculizumab may be needed in treatment; longitudinal extensive transverse myelitis (≥3 vertebral segments) may accompany on spinal cord MRI
Criteria
Anti-MOG antibody positive; long-segment perineuritis predominant; may be bilateral; can also be seen in children; steroid-responsive but relapse common
Distinct Features
Prominent perineural (sheath) enhancement on MRI — 'tram-track' or 'ring' pattern pathognomonic; optic nerve parenchymal enhancement may be less prominent; long-segment T2 hyperintensity but extension to chiasm less common than NMOSD; optic disc edema (papillitis) more common than MS-associated form; visual prognosis better than NMOSD but worse than MS; corticosteroid dependence common; ADEM-like presentation (especially in children)
Distinguishing Feature
Optic nerve sheath meningioma typically shows 'tram-track' enhancement (sheath enhances, nerve parenchyma preserved), slowly progressive vision loss (not acute), may have calcification on CT, nerve is enlarged; in optic neuritis, acute presentation, parenchymal enhancement predominant, no calcification, and enhancement resolves with treatment
Distinguishing Feature
Optic nerve glioma shows fusiform optic nerve thickening (may have kinking/buckling), seen in childhood (NF1 association), homogeneous T2 hyperintensity, variable enhancement; optic neuritis has acute presentation, nerve thickness normal or minimally increased, shows improvement with treatment
Distinguishing Feature
Idiopathic orbital inflammation (pseudotumor) in perineuritis form can involve the optic nerve sheath but generally diffuse inflammatory changes accompany throughout the orbit (extraocular muscles, lacrimal gland, orbital fat); optic neuritis shows isolated optic nerve involvement, inflammation in surrounding tissues is minimal or absent; steroid response present in both
Urgency
urgentManagement
medicalBiopsy
Not NeededFollow-up
Brain MRI at diagnosis for MS risk assessment; serial visual acuity, visual field, and OCT monitoring; follow-up brain MRI at 3-6 months; long-term neurological follow-up for MS conversionOptic neuritis requires urgent MRI evaluation and treatment. High-dose intravenous methylprednisolone (1 g/day, 3-5 days) is the standard treatment approach (ONTT study) — oral prednisone alone is contraindicated (increases relapse risk). Brain MRI is mandatory for MS diagnosis and risk assessment: with ≥2 white matter lesions, MS conversion risk is high and initiation of disease-modifying therapy (DMT) should be considered. Anti-AQP4 and anti-MOG antibodies should be tested to exclude NMOSD and MOG-IgG disease — treatment approach differs in these diseases (MS treatments may exacerbate NMOSD). Plasmapheresis, rituximab, or eculizumab may be needed in NMOSD. OCT (Optical Coherence Tomography) quantitatively evaluates axonal damage by measuring retinal nerve fiber layer thickness and provides prognosis prediction. Visual prognosis is generally good in typical MS-associated optic neuritis (recovery within 6 months in 90% of cases); prognosis is poor in NMOSD.
Steroid therapy accelerates visual recovery but does not change final visual outcome. Brain MRI and neurology consultation recommended due to MS association. 50% of patients develop MS within 15 years.